- Filed
- May 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 8, 2024 | 16.37B sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 16.37B sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 7.7B sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$119.04K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$221.8K |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $4.16M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $14.84K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $125.21K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$9.27M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$7.51M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $9.62M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $7.99M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $9.62M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $7.99M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $240.22K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $339.67K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $671.75K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $801.96K |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $88.04K |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $156.75K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$1.76M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$2.08M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$276.8K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$190.73K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $128.3K |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $132.89K |
| Revenue | Q1 2024 · Mar 31, 2024 | $401.55K |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $351.78K |